Click a link below to view the mailing archive as if it had been sent to you.
| 2018-05-31 22:42 | | CP Thursday Evening Premium: FDA news and the latest on the Inysys legal issue |
| 2018-05-31 12:30 | | CP Thursday Premium |
| 2018-05-30 22:33 | | CP Wednesday Evening Premium: Orphan drugs |
| 2018-05-30 13:09 | | CP Wednesday Premium: Allergan to sell units, plus a first look |
| 2018-05-29 23:12 | | CP Tuesday Evening Premium: M&A action and some device news |
| 2018-05-29 13:10 | | CP Tuesday Premium: Cancer news abounds |
| 2018-05-28 14:17 | | CP Monday Premium |
| 2018-05-26 10:24 | | CP Saturday Premium |
| 2018-05-25 13:31 | | CP Friday Premium: FDA actions and open workspaces |
| 2018-05-24 23:40 | | CP Thursday Evening Premium: Legal issues and clinical trials |
| 2018-05-24 13:28 | | CP Thursday Premium: Biotech launches |
| 2018-05-23 23:12 | | CP Wednesday Everning Premium: Abbott Labs serious recall |
| 2018-05-23 14:23 | | CP Wednesday Premium: Astellas restructuring |
| 2018-05-22 21:08 | | CP Tuesday Evening Premium: Right-to-try bill passed |
| 2018-05-22 13:20 | | CP Tuesday Premium: Clinical trial news and the Valeant-Philidor fraud case |
| 2018-05-21 23:26 | | CP Monday Evening Premium: FDA news |
| 2018-05-21 13:09 | | CP Monday Premium: Approvals and trial news |
| 2018-05-20 20:43 | | CP Sunday Premium |
| 2018-05-19 12:14 | | CP Saturday Premium |
| 2018-05-18 22:21 | | CP Friday Evening Premium: AstraZeneca and ASCO |
| 2018-05-18 14:00 | | CP Friday Premium: Microbiome database coming soon |
| 2018-05-18 00:14 | | CP Thursday Evening Premium: looking ahead to ASCO |
| 2018-05-17 13:39 | | CP Thursday Premium: FDA, clinical trials, and more |
| 2018-05-16 23:17 | | CP Wednesday Evening Premium: still more FDA news |
| 2018-05-16 12:44 | | CP Wednesday Premium: FDA news and more |
| 2018-05-15 23:38 | | CP Tuesday Evening Premium: drug rep licensing legislation |
| 2018-05-15 13:43 | | CP Tuesday Premium: new companies, legal issues, and more |
| 2018-05-15 00:10 | | CP Monday Evening Premium: new FDA rule, M&A news |
| 2018-05-14 12:42 | | CP Monday Premium: another drug developer acquisition for Lilly |
| 2018-05-13 16:01 | | CP Sunday Premium |
| 2018-05-12 13:49 | | CP Saturday Premium |
| 2018-05-11 22:37 | | CP Friday Evening Premium: Trump on drug pricing, plus lots of AI news |
| 2018-05-11 13:26 | | CP Friday Premium: the latest on NVS/Cohen and an AZ trial flop |
| 2018-05-11 00:11 | | CP Thursday Evening Premium: First look at our primer on phages |
| 2018-05-10 13:17 | | CP Thursday Premium: Lilly buying immuno-oncology firm |
| 2018-05-09 23:39 | | CP Wednesday Evening Premium: Novartis, Cohen, and biotech startups |
| 2018-05-09 12:23 | | CP Wednesday Premium: Mylan earnings, biotech news |
| 2018-05-08 22:38 | | CP Tuesday Evening Premium |
| 2018-05-08 12:13 | | CP Tuesday Premium: Takeda buying Shire |
| 2018-05-07 23:21 | | CP Monday Evening Premium: Takeda and Shire deal on the horizon? |
| 2018-05-07 13:22 | | CP Monday Premium: Diagnostics and Drug Pricing |
| 2018-05-06 18:16 | | CP Sunday Premium |
| 2018-05-05 12:24 | | CP Saturday Premium |
| 2018-05-04 22:52 | | CP Friday Evening Premium |
| 2018-05-04 12:37 | | CP Friday Premium: FDA actions, new Alzheimer's research, and more |
| 2018-05-03 23:40 | | CP Thursday Evening Premium |
| 2018-05-03 12:55 | | CP Thursday Premium: Merck Alzheimer's BACE Study Impact |
| 2018-05-02 23:47 | | CP Wednesday Evening Premium: More Cancer Drug News |
| 2018-05-02 12:36 | | CP Wednesday Premium: Updates in the Oncology Space |
| 2018-05-01 23:30 | | CP Tuesday Evening Premium: Earnings, Killing Tumors with CAR-T, and more |
| 2018-05-01 12:53 | | CP Tuesday Premium: a big PBM deal for Sanofi/Regeneron |
